|
1.
|
原著(症例報告除く)
|
Multi-hole Versus Fully Covered Self-expandable Metal Stents for Distal Biliary Obstruction in Unresectable Pancreatic Cancer. 2026/09
|
|
2.
|
原著(症例報告除く)
|
Prevalence and Outcomes of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease: A Multinational Study across Asia 2026/09
|
|
3.
|
原著(症例報告除く)
|
Effect of 5-Aminosalicylate Dose Reduction or Withdrawal on Prognosis in Patients with Ulcerative Colitis Receiving Advanced Therapy: A Multicenter Retrospective Cohort Study. 2026/08
|
|
4.
|
原著(症例報告除く)
|
Endoscopic management of common bile duct stones using double balloon endoscopy in postoperative patients: evaluation of single-session complete stone clearance. 2026/08
|
|
5.
|
原著(症例報告除く)
|
Association Between Cumulative Chemotherapy Exposure and Survival Outcomes in Advanced Biliary Tract Cancer. 2026/07
|
|
6.
|
原著(症例報告除く)
|
Paradoxical Change in the Gastric Microbiome Structure in the Helicobacter pylori-related Advanced Gastric Mucosal Atrophy. 2026/07
|
|
7.
|
その他
|
【潰瘍性大腸炎の個別化・層別化治療】治療シークエンスから見た潰瘍性大腸炎の治療戦略 2026/07
|
|
8.
|
原著(症例報告除く)
|
Clinical characteristics of acute pancreatitis in patients with inflammatory bowel disease: a nationwide survey in Japan. 2026/06
|
|
9.
|
その他
|
Clinical Issues of Endoscopic Treatment Strategies for Chronic Pancreatitis. 2026/06
|
|
10.
|
原著(症例報告除く)
|
Gel Immersion vs. Water Immersion Endoscopic Ultrasound for Visualization of the Duodenal Papilla and Periampullary Lesions: A Dual-Center Retrospective Study With Blinded Evaluation of Archived Videos. 2026/06
|
|
11.
|
その他
|
【多様化するBio製剤を基盤とした炎症性腸疾患治療戦略】総論 炎症性腸疾患に対するadvanced therapy 生物学的製剤を中心に 2026/05
|
|
12.
|
原著(症例報告除く)
|
Anesthesia with remimazolam versus dexmedetomidine and midazolam for the endoscopic submucosal dissection of the esophagus, stomach, and colorectum: A retrospective comparative study. 2026/04
|
|
13.
|
原著(症例報告除く)
|
Distinct difference of pancreatic tissue-specific microbiome in autoimmune pancreatitis and pancreatic ductal adenocarcinoma. 2026/04
|
|
14.
|
原著(症例報告除く)
|
Efficacy and Safety of Remimazolam Compared to Midazolam for Sedation During Endoscopic Ultrasonography: A Single-Center Retrospective Cohort Study. 2026/04
|
|
15.
|
原著(症例報告除く)
|
Enrichment of T: A→A: T substitutions in the TP53 gene in esophageal carcinoma with high Fusobacterium burden. 2026/04
|
|
16.
|
原著(症例報告除く)
|
[Second Publication] 内視鏡治療による無痛性膵石の完全除去は慢性膵炎患者における膵実質萎縮の進行を抑制する 多施設コホート研究 2026/03
|
|
17.
|
原著(症例報告除く)
|
Acute pancreatitis due to afferent loop obstruction treated by endoscopic ultrasound-guided transpancreatic afferent limb drainage. 2026/03
|
|
18.
|
原著(症例報告除く)
|
Diagnosis of Eosinophilic Enteritis Using Double-Balloon Enteroscopy-Guided Multisite Biopsies. 2026/03
|
|
19.
|
原著(症例報告除く)
|
Health-related quality of life before and after sobriety in combination with an adjunctive journaling application in patients with alcohol-related liver disease: a prospective single-arm study 2026/03
|
|
20.
|
症例報告
|
Hepatic Decompensation Caused by IgG4-positive Plasma Cell Infiltration Mimicking Sclerosing Cholangitis, Who Achieved a Four-year Survival by Glucocorticoid Treatment 2026/03
|
|
21.
|
原著(症例報告除く)
|
The Advanced Lung Cancer Inflammation Index as a Prognostic Indicator in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy. 2026/03
|
|
22.
|
その他
|
【炎症性腸疾患患者のQOLとその評価法を知る!】栄養・身体活動に関するQOL指標を知る! 2026/03
|
|
23.
|
その他
|
【大腸癌】フロントラインにとっての診療実践ガイド 炎症性腸疾患と大腸癌発症リスク管理 2026/03
|
|
24.
|
その他
|
【慢性膵炎診療の現状と課題】慢性膵炎に対する内視鏡治療の現状と課題 2026/03
|
|
25.
|
原著(症例報告除く)
|
Diagnostic accuracy of endoscopic findings for cytomegalovirus reactivation in hospitalized patients with ulcerative colitis. 2026/02
|
|
26.
|
その他
|
Efficacy and Safety of Remimazolam Compared to Midazolam for Sedation During Endoscopic Ultrasonography: A Single-Center Retrospective Cohort Study 2026/02
|
|
27.
|
その他
|
Interaction of host genetic factor and gastric microbiome in DNA methylation induction. 2026/02
|
|
28.
|
原著(症例報告除く)
|
A Multicenter Observational Study for the Establishment of Novel Severity Criteria Including Endoscopic Evaluation for Intestinal Behçet's Disease. 2026/01
|
|
29.
|
総説
|
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2024 for the Clinical Practice of Inflammatory Bowel Disease-Associated Intestinal Neoplasia (English Version). 2026/01
|
|
30.
|
原著(症例報告除く)
|
Post-electrocoagulation Syndrome Following APC Treatment for Angiodysplasia in the Ascending Colon: A Case Report. 2026/01
|
|
31.
|
その他
|
【炎症性腸疾患 研究と臨床の最新知見】炎症性腸疾患に対する新規薬剤 JAK阻害薬のメカニズムから臨床成績まで 2026/01
|
|
32.
|
原著(症例報告除く)
|
Cachexia Index as a Prognostic Indicator in Patients with Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy 2026
|
|
33.
|
症例報告
|
New method; continuous water perfusion method during endoscopic resection for the superficial pharyngeal squamous cell carcinoma. 2025/12
|
|
34.
|
原著(症例報告除く)
|
Non-injection resection using bipolar soft coagulation mode for large colorectal polyps including incidental cancer. 2025/12
|
|
35.
|
その他
|
【消化管感染症のすべて2025】十二指腸-小腸 (C)ウイルス感染 サイトメガロウイルス腸炎(十二指腸～小腸) 2025/12
|
|
36.
|
原著(症例報告除く)
|
Gastric microbiome in gastric cancer sequence depicts diverse microbial structures associated with cancer risk and prognosis. 2025/10
|
|
37.
|
原著(症例報告除く)
|
The Gastric Microbiome Communities and Endoscopic Mucosal Morphologies Associated with Premalignant Conditions. 2025/10
|
|
38.
|
総説
|
【便通異常症の最新知識】下痢をきたす疾患 薬剤性腸炎 2025/10
|
|
39.
|
その他
|
Effective endoscopic diagnosis for neoplastic or non-neoplastic reddish depressed lesions after H. pylori eradication. 2025/09
|
|
40.
|
原著(症例報告除く)
|
Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic Cancer. 2025/08
|
|
41.
|
原著(症例報告除く)
|
Hepatic Sarcoidosis Mimicking a Metastatic Tumor: A Case Report 2025/08
|
|
42.
|
原著(症例報告除く)
|
Usefulness and Safety of Endoscopic Nasobiliary Drainage for Type 1 Autoimmune Pancreatitis 2025/08
|
|
43.
|
その他
|
【周産期の薬物療法 update 2025 産科編】妊娠中の合併症 炎症性腸疾患 2025/08
|
|
44.
|
原著(症例報告除く)
|
Post Hoc Analysis of Anxiety and Behavioral Changes in Japanese Patients With Inflammatory Bowel Disease due to the COVID-19 Pandemic: Relationship Between Municipal Population at the Place of Residence and Anxiety. 2025/07
|
|
45.
|
原著(症例報告除く)
|
Carbohydrate-Deficient Transferrin Evaluation Over Time Has Usefulness for Confirming Sobriety of Alcohol Rehabilitation Program Patients. 2025/06
|
|
46.
|
原著(症例報告除く)
|
Complete clearance of painless pancreatic stones with endotherapy prevents the progression of pancreatic parenchyma atrophy in patients with chronic pancreatitis: Multicenter cohort study 2025/06
|
|
47.
|
その他
|
IBD治療薬のコンセンサスとエビデンスを中心とした考察(第6回) ウパダシチニブ 2025/06
|
|
48.
|
原著(症例報告除く)
|
Prevalence and predictability of the Chicago Classification of Pouchitis in ulcerative colitis: a multicenter study in Japan 2025/06
|
|
49.
|
症例報告
|
Antitumor Necrosis Factor-Refractory Esophageal Lesions in Crohn's Disease Successfully Treated With Upadacitinib. 2025/05
|
|
50.
|
原著(症例報告除く)
|
Clinical Outcomes for Patients With Ulcerative Colitis in Cases of Withdrawal and Resumption of Janus Kinase Inhibitors: Multicenter Cohort Study 2025/04
|
|
51.
|
原著(症例報告除く)
|
First-line biologics as a treatment for ulcerative colitis: a multicenter randomized control study 2025/04
|
|
52.
|
総説
|
Guidelines for endoscopic diagnosis and treatment of inflammatory bowel diseases 2025/04
|
|
53.
|
原著(症例報告除く)
|
Leucine-rich alpha-2 glycoprotein is useful in predicting clinical relapse in patients with Crohn's disease during biological remission 2025/04
|
|
54.
|
原著(症例報告除く)
|
Behçet's disease: incidence, prevalence, and real-word data on the use of biologic agents in Japan 2025/03
|
|
55.
|
原著(症例報告除く)
|
Efficacy of Dose Escalation of Oral 5-Aminosalicylic Acid for Ulcerative Colitis With a Mayo Endoscopic Subscore of 1: An Open Label Randomized Controlled Trial 2025/03
|
|
56.
|
総説
|
【IBD診療におけるモニタリングを極める!】Patient-Reported Outcomes(PRO)によるモニタリングを極める! 2025/03
|
|
57.
|
原著(症例報告除く)
|
炎症性腸疾患に伴う食道病変の臨床的・内視鏡的特徴 2025/03
|
|
58.
|
原著(症例報告除く)
|
Effectiveness and outcomes of endoscopic resection for superficial pharyngeal squamous cell carcinomas 2025/02
|
|
59.
|
原著(症例報告除く)
|
Reply to "Severe ulcerative colitis: diagnostic criteria and therapy" 2025/02
|
|
60.
|
総説
|
【膵外分泌機能不全を再考する】治療 高力価膵消化酵素薬使用のポイント 2025/02
|
|
61.
|
原著(症例報告除く)
|
Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study 2025/01
|
|
62.
|
総説
|
Assessment of IL-6 Pathway Inhibition in Gastrointestinal Behçet's Disease from Immunological and Clinical Perspectives 2025/01
|
|
63.
|
総説
|
【炎症性腸疾患(IBD)診療の現況】潰瘍性大腸炎の内科治療 2025/01
|
|
64.
|
その他
|
Immunoregulatory Functions of Tumor-Derived Extracellular Vesicles: Emerging Insights into Cancer Control 2025
|
|
65.
|
原著(症例報告除く)
|
Distinct microbiome dysbiosis and epigenetic anomaly in esophageal adenocarcinoma and its underlying Barrett's esophagus 2024/12
|
|
66.
|
総説
|
【回盲部・虫垂病変の診断】腸管Behcet病 2024/12
|
|
67.
|
総説
|
治療法の再整理とアップデートのために 専門家による私の治療 潰瘍性大腸炎 2024/12
|
|
68.
|
原著(症例報告除く)
|
腸管Beçhet病 2024/12
|
|
69.
|
原著(症例報告除く)
|
膵原発のpure hepatoid carcinomaの1例 2024/12
|
|
70.
|
原著(症例報告除く)
|
Gastric microbiome composition accompanied with the Helicobacter pylori related DNA methylation anomaly 2024/11
|
|
71.
|
原著(症例報告除く)
|
Impact of twice-daily budesonide foam administration on early clinical response and endoscopic remission in patients with ulcerative colitis: a post hoc analysis 2024/11
|
|
72.
|
原著(症例報告除く)
|
Platelet activation through CD62P and the formation of platelet-monocyte complexes are associated with the exacerbation of mucosal inflammation in patients with ulcerative colitis 2024/11
|
|
73.
|
総説
|
特集 炎症性腸疾患 躍進の時代を迎えた炎症性腸疾患診療 座談会 2024/11
|
|
74.
|
原著(症例報告除く)
|
A method of "Noninjecting Resection using Bipolar Soft coagulation mode; NIRBS" for superficial non-ampullary duodenal epithelial tumor: a pilot study 2024/10
|
|
75.
|
総説
|
【炎症性腸疾患2024】炎症性腸疾患の内科治療 血球成分吸着除去療法 2024/10
|
|
76.
|
原著(症例報告除く)
|
血球成分吸着除去法療法 2024/10
|
|
77.
|
原著(症例報告除く)
|
Efficacy of upadacitinib in the achievement of clinical and endoscopic remission in hospitalized patients with ulcerative colitis 2024/08
|
|
78.
|
原著(症例報告除く)
|
Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or borderline resectable pancreatic ductal adenocarcinoma 2024/08
|
|
79.
|
原著(症例報告除く)
|
Microbiome of esophageal endoscopic wash samples is associated with resident flora in the esophagus and incidence of cancer 2024/08
|
|
80.
|
原著(症例報告除く)
|
Efficacy of lenvatinib and transarterial chemoembolization combination therapy in patients with hepatocellular carcinoma administered an insufficient dose of early lenvatinib 2024/07
|
|
81.
|
原著(症例報告除く)
|
Fusobacterium Detected in Barrett's Esophagus and Esophageal Adenocarcinoma Tissues 2024/07
|
|
82.
|
原著(症例報告除く)
|
Reply to "promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy" 2024/07
|
|
83.
|
原著(症例報告除く)
|
Real-world NUDT15 genotyping and thiopurine treatment optimization in inflammatory bowel disease: a multicenter study. 2024/06
|
|
84.
|
原著(症例報告除く)
|
Safety of immune checkpoint inhibitors in patients aged over 80 years: a retrospective cohort study 2024/05
|
|
85.
|
原著(症例報告除く)
|
Medical treatment selection and outcomes for hospitalized patients with severe ulcerative colitis as defined by the Japanese criteria 2024/04
|
|
86.
|
原著(症例報告除く)
|
Clinical outcomes of patients with remitting ulcerative colitis after discontinuation of indigo naturalis 2024/03
|
|
87.
|
原著(症例報告除く)
|
Injury to the Muscle Layer and Risk of Non-cardiac Chest Pain after Endoscopic Submucosal Dissection for Esophageal Cancer 2024/03
|
|
88.
|
その他
|
【IBDの謎を科学する】インジゴナチュラリス(インジゴ)の謎を科学する 2024/03
|
|
89.
|
原著(症例報告除く)
|
【ここまで進歩した!クローン病治療～難治性病態に対する有効性を作用点から】線維化に対する有効性 サイトカインを標的とした治療の線維化に対する影響を考察する(TNFαとIL-23の違いを含めて) 2024/03
|
|
90.
|
原著(症例報告除く)
|
Effective hemostasis under gel immersion endoscopy using inflated balloons on the tip of double balloon endoscope for active bleeding in the small intestine 2024/02
|
|
91.
|
原著(症例報告除く)
|
Helicobacter pylori infection associated DNA methylation in primary gastric cancer significantly correlates with specific molecular and clinicopathological features 2024/02
|
|
92.
|
原著(症例報告除く)
|
Nationwide multicenter study on adverse events associated with a patency capsule: Additional survey of appropriate use of patency capsule study 2024/02
|
|
93.
|
症例報告
|
Successful endoscopic resection for well-differentiated neuroendocrine tumor, Grade 1, in the hypopharynx 2024/02
|
|
94.
|
原著(症例報告除く)
|
Prospective feasibility study of indigo naturalis ointment for chemotherapy-induced oral mucositis 2024/01
|
|
95.
|
総説
|
炎症性腸疾患におけるアフェレシス療法の過去・現在・未来 2024
|
|
96.
|
その他
|
Gel immersion endoscopic papillectomy using a double-balloon endoscope to resect an ampullary tumor 2023/12
|
|
97.
|
原著(症例報告除く)
|
Herpetic esophagitis in healthy young adult 2023/12
|
|
98.
|
原著(症例報告除く)
|
Narrowing the Patient-Physician Gap Based on Self-Reporting and Monthly Hepatologist Feedback for Patients With Alcohol-Related Liver Disease: Interventional Pilot Study Using a Journaling Smartphone App 2023/12
|
|
99.
|
症例報告
|
Primary Gastric Rhabdomyosarcoma: A Case Report 2023/12
|
|
100.
|
原著(症例報告除く)
|
Real-world efficacy and safety of advanced therapies in hospitalized patients with ulcerative colitis 2023/12
|
|
101.
|
その他
|
【潰瘍性大腸炎について基本から最新まで改めて学んでみよう】潰瘍性大腸炎治療における低分子化合物の選択とそれぞれの特徴 2023/12
|
|
102.
|
原著(症例報告除く)
|
Intravenous injection of tumor extracellular vesicles suppresses tumor growth by reducing the regulatory T cell phenotype 2023/11
|
|
103.
|
原著(症例報告除く)
|
Long-term Outcomes after Steroid Pulse Therapy in Patients with Type 1 Autoimmune Pancreatitis 2023/10
|
|
104.
|
原著(症例報告除く)
|
Evaluation of a new method “Noninjection Resection using Bipolar Soft coagulation mode; NIRBS” for colonic adenomatous lesions． 2023/09
|
|
105.
|
原著(症例報告除く)
|
Perforation-free removal of gastric gastrointestinal stromal tumors: Endoscopic inversion and strangulation of muscle layer and resection (EISMR) 2023/09
|
|
106.
|
原著(症例報告除く)
|
Telomere shortening of Barrett's esophagus and esophageal adenocarcinoma in Japanese patients 2023/09
|
|
107.
|
症例報告
|
急激に進行し後にEpstein-Barrウイルス再活性化の関与が疑われた急性肝不全昏睡型の一例 2023/09
|
|
108.
|
原著(症例報告除く)
|
Combined serum albumin, fecal immunochemical test, and leucine-rich alpha-2 glycoprotein levels for predicting prognosis in remitting patients with ulcerative colitis 2023/08
|
|
109.
|
原著(症例報告除く)
|
Comprehensive DNA methylation profiling of Barrett's esophagus and esophageal adenocarcinoma in Japanese patients 2023/08
|
|
110.
|
原著(症例報告除く)
|
Microarchitectures of Barrett's esophagus associated with DNA methylation status 2023/08
|
|
111.
|
原著(症例報告除く)
|
A Short-Term Model of Colitis-Associated Colorectal Cancer That Suggests Initial Tumor Development and the Characteristics of Cancer Stem Cells 2023/07
|
|
112.
|
原著(症例報告除く)
|
The critical role of Rap1-GAPs Rasa3 and Sipa1 in T cells for pulmonary transit and egress from the lymph nodes 2023/07
|
|
113.
|
原著(症例報告除く)
|
Thymocyte Development of Humanized Mice Is Promoted by Interactions with Human-Derived Antigen Presenting Cells upon Immunization 2023/07
|
|
114.
|
原著(症例報告除く)
|
Impact of neoadjuvant therapy on gut microbiome in patients with resectable/borderline resectable pancreatic ductal adenocarcinoma 2023/06
|
|
115.
|
その他
|
ここまできた分子標的薬・抗体製剤の最新情報from A to Z No,22 潰瘍性大腸炎の分子標的薬 2023/06
|
|
116.
|
原著(症例報告除く)
|
A new endoscopic scoring system corresponding to histological healing using linked color imaging in ulcerative colitis: the SOUL study 2023/05
|
|
117.
|
原著(症例報告除く)
|
A Retrospective Study Investigating the Safety and Efficacy of Nanoliposomal Irinotecan in Elderly Patients with Unresectable Pancreatic Cancer 2023/05
|
|
118.
|
原著(症例報告除く)
|
Cardiac 18F‑FDG uptake and new‑onset rectal cancer 2023/05
|
|
119.
|
原著(症例報告除く)
|
Endoscopic features of lymphoid follicles in the colonic mucosa using the image enhanced endoscopy and its association with colorectal adenoma 2023/05
|
|
120.
|
原著(症例報告除く)
|
Establishment of a Novel Colitis-Associated Cancer Mouse Model Showing Flat Invasive Neoplasia 2023/05
|
|
121.
|
原著(症例報告除く)
|
【消化管の疾患と皮膚病変】JAK阻害薬にてコントロールしえた潰瘍性大腸炎を合併した壊疽性膿皮症 2023/05
|
|
122.
|
症例報告
|
A case of type 2 autoimmune pancreatitis with spontaneous remission 2023/04
|
|
123.
|
その他
|
Correction to: Expert consensus on vaccination in patients with inflammatory bowel disease in Japan 2023/04
|
|
124.
|
原著(症例報告除く)
|
Efficacy and safety of endoscopic stent placement for afferent loop obstruction using a short double-balloon endoscopy. 2023/04
|
|
125.
|
総説
|
Treatment escalation and de-escalation decisions in Crohn's disease: Delphi consensus recommendations from Japan, 2021 2023/04
|
|
126.
|
原著(症例報告除く)
|
Usefulness of texture and color enhancement imaging (TXI) in early gastric cancer found after Helicobacter pylori eradication 2023/04
|
|
127.
|
総説
|
【プライマリケア医に必要な情報をまるっと整理 くすりの使い方便利帳】(第5章)消化器系に作用する薬剤 下部消化管疾患治療薬 炎症性腸疾患治療薬 2023/04
|
|
128.
|
症例報告
|
Difficult to evaluate obstructive colorectal cancer diagnosed by gel immersion endoscopy - A video vignette 2023/03
|
|
129.
|
その他
|
Endoscopic resection of a gastric gastrointestinal stromal tumor without perforation using a detachable snare. 2023/03
|
|
130.
|
原著(症例報告除く)
|
UCにおけるバイオ製剤の選択 2023/03
|
|
131.
|
総説
|
治療法の再整理とアップデートのために 専門家による私の治療 腸管ベーチェット病/単純性潰瘍 2023/02
|
|
132.
|
症例報告
|
A case of type 2 autoimmune pancreatitis with spontaneous remission 2023/01
|
|
133.
|
原著(症例報告除く)
|
Endoscopic approach for a pinhole-like benign stenosis in a pancreaticojejunal anastomosis using a double-balloon endoscope with a clear long cap attachment 2022/12
|
|
134.
|
その他
|
Interleukin-35はIgG4関連1型自己免疫性膵炎の制御性T細胞の分化を誘導し,Th2免疫応答を抑制する 2022/12
|
|
135.
|
総説
|
【IBDの既存治療を最新の知見から見直す!】 IBDのチオプリン製剤による治療を見直す. 2022/12
|
|
136.
|
総説
|
【急性膵炎をめぐる諸問題】厚生労働省重症度判定基準の課題(国際比較も含めて) 2022/11
|
|
137.
|
症例報告
|
Percutaneous transhepatic obliteration for rupture of varices in the small intestine: a case report 2022/10
|
|
138.
|
総説
|
【IgG4関連疾患大全-自己免疫性膵炎とIgG4関連硬化性胆管炎を中心に-】自己免疫性膵炎 自己免疫性膵炎と膵癌との関係性 2022/10
|
|
139.
|
総説
|
抗体製剤の特徴とその使い分け 2022/10
|
|
140.
|
原著(症例報告除く)
|
顆粒型側方発育型大腸腫瘍(LST-G)を病変内に認めた腸間膜静脈硬化症の1症例 2022/10
|
|
141.
|
総説
|
IBD難治例への対応 2022/09
|
|
142.
|
総説
|
青黛 2022/09
|
|
143.
|
原著(症例報告除く)
|
Analysis of the initial dose and reduction rate of corticosteroid for ulcerative colitis in clinical practice 2022/08
|
|
144.
|
原著(症例報告除く)
|
Repeated Stimulation of Toll-Like Receptor 2 and Dectin-1 Induces Chronic Pancreatitis in Mice Through the Participation of Acquired Immunity 2022/08
|
|
145.
|
総説
|
Viral Infection in Esophageal, Gastric, and Colorectal Cancer 2022/08
|
|
146.
|
原著(症例報告除く)
|
Gel Immersion Endoscopic Mucosal Resection (EMR) for Superficial Nonampullary Duodenal Epithelial Tumors May Reduce Procedure Time Compared with Underwater EMR (with Video) 2022/06
|
|
147.
|
原著(症例報告除く)
|
High tumor budding predicts a poor prognosis in resected duodenal adenocarcinoma 2022/06
|
|
148.
|
総説
|
Smad3 Phospho-Isoform Signaling in Nonalcoholic Steatohepatitis 2022/06
|
|
149.
|
総説
|
【実践!最新のIBD病勢モニタリング】便マーカー(カルプロテクチン、FIT)の活用法 2022/06
|
|
150.
|
総説
|
【潰瘍性大腸炎 内科診療の即戦力を身につける!-急増する患者の日常診療に求められる必須アップデート-】潰瘍性大腸炎 治療指針とガイドライン 最新版の改訂ポイントを押さえる 2022/06
|
|
151.
|
原著(症例報告除く)
|
術後再建腸管を有する胆膵疾患に対するバルーン式内視鏡を用いた内視鏡的逆行性胆管膵管造影の最近の進歩：治療戦略と困難症例の対処方法 2022/06
|
|
152.
|
症例報告
|
Endoscopic retrieval of a migrated surgical clip in a choledochojejunal anastomosis using the rendezvous technique 2022/05
|
|
153.
|
総説
|
疾患 下部消化管 潰瘍性大腸炎 2022/05
|
|
154.
|
総説
|
A review on the current status and definitions of activity indices in inflammatory bowel disease: how to use indices for precise evaluation 2022/04
|
|
155.
|
原著(症例報告除く)
|
Colectomy risk score predicts pouchitis in patients with ulcerative colitis 2022/04
|
|
156.
|
原著(症例報告除く)
|
Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS) 2022/03
|
|
157.
|
総説
|
【炎症性腸疾患update-診断・治療の最新知見-】炎症性腸疾患の治療 薬物治療 ステロイド治療 2022/03
|
|
158.
|
総説
|
潰瘍性大腸炎における粘膜治癒評価の意義 通常内視鏡の立場から 2022/02
|
|
159.
|
総説
|
A consensus statement on health-care transition for childhood-onset inflammatory bowel disease patients 2022/01
|
|
160.
|
原著(症例報告除く)
|
A nationwide survey concerning the mortality and risk of progressing severity due to arterial and venous thromboembolism in inflammatory bowel disease in Japan 2021/12
|
|
161.
|
原著(症例報告除く)
|
Phospho-Smad3 signaling is predictive biomarker for hepatocellular carcinoma risk assessment in primary biliary cholangitis patients 2021/12
|
|
162.
|
原著(症例報告除く)
|
The Japanese Society for Apheresis clinical practice guideline for therapeutic apheresis 2021/12
|
|
163.
|
原著(症例報告除く)
|
Utility of biopsy forceps lavage cytology in diagnosing malignant biliary stricture : Don't waste the sample for pathological examination 2021/11
|
|
164.
|
原著(症例報告除く)
|
Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis: Comparison of cases with and without autoimmune pancreatitis in a large cohort 2021/10
|
|
165.
|
原著(症例報告除く)
|
Linker Threonine-phosphorylated Smad2/3 Is a Biomarker of Colorectal Neoplastic Stem-like Cells that Correlates With Carcinogenesis 2021/10
|
|
166.
|
原著(症例報告除く)
|
Characteristics of the Mucosal Surface on Scanning Electron Microscopy in Patients with Remitting Ulcerative Colitis 2021/09
|
|
167.
|
原著(症例報告除く)
|
Recent advances of endoscopic retrograde cholangiopancreatography using balloon assisted endoscopy for pancreaticobiliary diseases in patients with surgically altered anatomy: Therapeutic strategy and management of difficult cases 2021/09
|
|
168.
|
総説
|
炎症性腸疾患に対する分子標的治療 2021/09
|
|
169.
|
総説
|
炎症性腸疾患は外来で治療できる 2021/09
|
|
170.
|
総説
|
最新のガイドラインからみた潰瘍性大腸炎内科治療 2021/09
|
|
171.
|
原著(症例報告除く)
|
Efficacy of microwave ablation versus radiofrequency ablation for hepatocellular carcinoma: a propensity score analysis 2021/08
|
|
172.
|
症例報告
|
Large Metastatic Cardiac Tumor from Ascending Colon Cancer with Autopsy. 2021/08
|
|
173.
|
原著(症例報告除く)
|
Phase 1 study on the safety and efficacy of E6011, antifractalkine antibody, in patients with Crohn's disease 2021/08
|
|
174.
|
原著(症例報告除く)
|
Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitis 2021/08
|
|
175.
|
原著(症例報告除く)
|
Rectally Administered Low-Dose Diclofenac Has No Effect on Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Propensity Score Analysis. 2021/08
|
|
176.
|
総説
|
炎症性腸疾患に対する生物学的製剤・JAK阻害剤―IBD診療ガイドライン2020を読み解く― 2021/07
|
|
177.
|
症例報告
|
Development of Severe Acute Pancreatitis Following Uncovered Metallic Stent Placement: A Rare Case Report 2021/06
|
|
178.
|
原著(症例報告除く)
|
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020 2021/06
|
|
179.
|
総説
|
【膵臓症候群(第3版)-その他の膵臓疾患を含めて-】膵神経内分泌腫瘍 インスリノーマ 2021/06
|
|
180.
|
総説
|
サイトメガロウイルス(CMV)腸炎合併(疑いを含む)活動性潰瘍性大腸炎に対する抗ウイルス薬は必要か？ 2021/06
|
|
181.
|
総説
|
【炎症性腸疾患診療の新たな展開】潰瘍性大腸炎 薬物療法 2021/05
|
|
182.
|
症例報告
|
A giant Brunner gland hamartoma successfully treated by endoscopic excision followed by transanal retrieval: A case report 2021/04
|
|
183.
|
原著(症例報告除く)
|
Demarcated redness associated with increased vascular density/size: a useful marker of flat-type dysplasia in patients with ulcerative colitis 2021/04
|
|
184.
|
原著(症例報告除く)
|
Serum free light chain assessment in type 1 autoimmune pancreatitis 2021/04
|
|
185.
|
総説
|
【内科疾患の診断基準・病型分類・重症度】(第2章)消化器 炎症性腸疾患 2021/04
|
|
186.
|
総説
|
炎症性腸疾患の既存治療 ―5-ASA製剤、ステロイド製剤、チオプリン製剤― 2021/04
|
|
187.
|
原著(症例報告除く)
|
Endoscopic retrieval of a migrated biliary stent into intrahepatic bile duct by using fine-gauge biliary balloon dilation catheter 2021/03
|
|
188.
|
総説
|
炎症性腸疾患における画像検査の疾患活動性評価とTreat-to Targetの意義 2021/03
|
|
189.
|
原著(症例報告除く)
|
Non-adherence to Medications in Pregnant Ulcerative Colitis Patients Contributes to Disease Flares and Adverse Pregnancy Outcomes 2021/02
|
|
190.
|
原著(症例報告除く)
|
Pulmonary Arterial Hypertension Caused by AhR Signal Activation Protecting against Colitis 2021/02
|
|
191.
|
症例報告
|
Internal biliary drainage using double-balloon endoscopy in a patient with complete obstruction of the hepaticojejunostomy site 2021/01
|
|
192.
|
その他
|
Reply 2021/01
|
|
193.
|
原著(症例報告除く)
|
Significance of endoscopic deep small bowel evaluation using balloon-assisted enteroscopy for Crohn's disease in clinical remission 2021/01
|
|
194.
|
総説
|
【急性膵炎診療up-to-date】診断 日本の厚生労働省重症度判定基準の課題 2021/01
|
|
195.
|
総説
|
検査ONE POINT 炎症性腸疾患における検査 便中カルプロテクチン検査を中心に 2021/01
|
|
196.
|
原著(症例報告除く)
|
Usefulness of half‐covered metallic stent placement in preventing acute cholecystitis complication in pancreatic cancer‐induced distal biliary stricture. 2020/12
|
|
197.
|
総説
|
多様化するIBD診断と治療はどう治療選択に影響するのか？ 2020/12
|
|
198.
|
総説
|
Solving the questions regarding 5-aminosalitylate formulation in the treatment of ulcerative colitis. 2020/11
|
|
199.
|
総説
|
潰瘍性大腸炎におけるcolitis-associated cancer-診断の現状と問題点- 2020/11
|
|
200.
|
その他
|
Efficacy of Novel Ultrathin Single-Balloon Enteroscopy for Crohn's Disease: A Propensity Score-Matched Study 2020/09
|
|
201.
|
総説
|
IBDに対する漢方薬・生薬 2020/09
|
|
202.
|
原著(症例報告除く)
|
The Utility of the Colectomy Risk Score in Terms of Predicting Postoperative Complications in Patients with Ulcerative Colitis 2020/09
|
|
203.
|
原著(症例報告除く)
|
Usefulness of half-covered metallic stent placement in preventing acute cholecystitis complication in pancreatic cancer-induced distal biliary stricture. 2020/09
|
|
204.
|
原著(症例報告除く)
|
IBD治療における青黛の有用性と安全性 2020/08
|
|
205.
|
原著(症例報告除く)
|
【特大号】ダブルバルーン小腸内視鏡を用いた肝内結石治療のコツとトラブルシューティング 2020/08
|
|
206.
|
総説
|
Clinical ,Endscopic,and Pathological Characterisitics of immune Checkpoint inhibitor-Induced Gastroenterocolitis. 2020/07
|
|
207.
|
原著(症例報告除く)
|
Clinical, Endoscopic, and Pathological Characteristics of Immune Checkpoint Inhibitor-Induced Gastroenterocolitis 2020/07
|
|
208.
|
総説
|
Intimal sarcoma of the pulmonary artery without 18F-fluorodeoxyglucose uptake 2020/06
|
|
209.
|
原著(症例報告除く)
|
IBDに対する血液成分吸着除去療法：
過去・現在・未来 2020/05
|
|
210.
|
原著(症例報告除く)
|
Efficacy of apheresis as maintenance therapy for patients with ulcerative colitis in an open-label prospective multicenter randomised controlled trial 2020/04
|
|
211.
|
原著(症例報告除く)
|
Mucosal concentrations of N-acetyl-5-aminosalicylic acid related to endoscopic activity in ulcerative colitis patients with mesalamine 2020/04
|
|
212.
|
総説
|
5-Aminosalicylic acid intolerance is associated with a risk of adverse clinical outcomes and dysbiosis in patients with ulcerative colitis. 2020/01
|
|
213.
|
症例報告
|
Intramucosal poorly differentiated and signet-ring cell components in patients with ulcerative colitis-associated high-grade dysplasia. 2019/11
|
|
214.
|
原著(症例報告除く)
|
Adverse events in patients with ulcerative colitis treated with indigo naturalis: a Japanese nationwide survey. 2019/10
|
|
215.
|
原著(症例報告除く)
|
Long-term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine. 2019/10
|
|
216.
|
原著(症例報告除く)
|
Difference in the clinical characteristic and prognosis of colitis-associated cancer and sporadic neoplasia in ulcerative colitis patients 2019/09
|
|
217.
|
総説
|
Management of elderly ulcerative colitis in Japan 2019/07
|
|
218.
|
原著(症例報告除く)
|
Endoscopic characteristics of small intestinal malignant tumors observed by balloon-assisted enteroscopy 2019/05
|
|
219.
|
総説
|
How Can We Assess "Complete Healing" Beyond Endoscopic Remission? 2019/05
|
|
220.
|
総説
|
Treatment with indigo naturalis for inflammatory bowel disease and other immune diseases 2019/05
|
|
221.
|
総説
|
Current new challenges in the management of ulcerative colitis. Intest Res. 2019
|
|
222.
|
症例報告
|
Thrombocytopenic Purpura Responsive to Surgery for Crohn's Disease. 2019
|
|
223.
|
原著(症例報告除く)
|
Withdrawal of thiopurines in Crohn's disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2). 2019
|
|
224.
|
原著(症例報告除く)
|
5-Aminosalicylic acid aggravates colitis mimicking exacerbation of ulcerative colitis 2018/10
|
|
225.
|
原著(症例報告除く)
|
Factors predicting the therapeutic response to infliximab during maintenance therapy in Japanese patients with Crohn's disease 2018/10
|
|
226.
|
原著(症例報告除く)
|
Insertability comparison of passive bending single-balloon prototype versus standard single-balloon enteroscopy: a multicenter randomized non-blinded trial. 2018/10
|
|
227.
|
原著(症例報告除く)
|
NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study. 2018/09
|
|
228.
|
原著(症例報告除く)
|
Toll-Like Receptor 7 Agonist-Induced Dermatitis Causes Severe Dextran Sulfate Sodium Colitis by Altering the Gut Microbiome and Immune Cells. 2018/09
|
|
229.
|
総説
|
Reply:(for Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis.for Pulmonary Arterial Hypertension Associated With the Chinese Herb Indigo Naturalis for Ulcerative Colitis: It May Be Reversible) 2018/08
|
|
230.
|
原著(症例報告除く)
|
Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial 2018/07
|
|
231.
|
原著(症例報告除く)
|
β-(1,3)-Glucan derived from Candida albicans induces inflammatory cytokines from macrophages and lamina propria mononuclear cells derived from patients with Crohn's disease 2018/07
|
|
232.
|
原著(症例報告除く)
|
Efficacy of Indigo naturalis in a Multicenter Randomized Controlled Trial of Patients with Ulcerative Colitis. 2018/03
|
|
233.
|
総説
|
Can budesonide form be alterative treatment for ulcerative proctosigmoiditis? 2018
|
|
234.
|
症例報告
|
Increased levels of prostaglandin E-major urinary metabolite (PGE-MUM) in active mesenteric panniculitis patients 2017/12
|
|
235.
|
その他
|
Reply to Gheorghe et al. (for The role of confocal laser endomicroscopy in assessing mucosal healing in patients with ulcerative proctitis) 2017/12
|
|
236.
|
原著(症例報告除く)
|
The risk factor of clinical relapse in ulcerative colitis patients with low dose 5-aminosalicylic acid as maintenance therapy: A report from the IBDregistry. 2017/11
|
|
237.
|
原著(症例報告除く)
|
Chronic enteropathy associated with SLCO2A1 gene (CEAS) - Characterization of an enteric disorder to be considered in the differential diagnosis of Crohn's disease. 2017/10
|
|
238.
|
原著(症例報告除く)
|
Intestinal Dysbiosis and Biotin Deprivation Induce Alopecia through Overgrowth of Lactobacillus murinus in Mice. 2017/08
|
|
239.
|
原著(症例報告除く)
|
Long-term safety and efficacy of adalimumab for intestinal Behçet's disease in the open label study following a phase 3 clinical trial 2017/07
|
|
240.
|
原著(症例報告除く)
|
Surveillance for Dysplasia in Patients with Ulcerative Colitis: Discrepancy between Guidelines and Practice 2017/07
|
|
241.
|
原著(症例報告除く)
|
Difficulties in performing mesalazine enemas and factors related to discontinuation among patients with ulcerative colitis 2017/03
|
|
242.
|
原著(症例報告除く)
|
Endoscopic morphological features of ulcerative colitis-associated dysplasia classified according to the SCENIC consensus statement 2017/03
|
|
243.
|
原著(症例報告除く)
|
Glycolysis regulates LPS-induced cytokine production in M2 polarized human macrophages 2017/03
|
|
244.
|
原著(症例報告除く)
|
Evaluation of the severity of ulcerative colitis using endoscopic dual red imaging targeting deep vessels 2017/01
|
|
245.
|
原著(症例報告除く)
|
Findings of ulceration and severe stricture on MRE can predict prognosis of Crohn's disease in patients treated with anti-TNF treatment 2017/01
|
|
246.
|
原著(症例報告除く)
|
Single fecal microbiota transplantation failed to change intestinal microbiota and had limited effectiveness against ulcerative colitis in Japanese patients 2017/01
|
|
247.
|
原著(症例報告除く)
|
What strategies do ulcerative colitis patients employ to facilitate adherence? 2017/01
|
|
248.
|
原著(症例報告除く)
|
Bifidobacterium-rich fecal donor may be a positive predictor for successful fecal microbiota transplantation in patients with irritable bowel syndrome 2017
|
|
249.
|
原著(症例報告除く)
|
Endocytoscopy can be used to assess histological healing in ulcerative colitis patients with clinical and endoscopic remission. 2017
|
|
250.
|
原著(症例報告除く)
|
Limited identification of dual-time-point positron emission tomography/computed tomography in advanced colorectal neoplasms 2017
|
|
251.
|
原著(症例報告除く)
|
A Single Species of Clostridium Subcluster XIVa Decreased in Ulcerative Colitis Patients 2016/12
|
|
252.
|
総説
|
Recent trends and future directions for the medical treatment of ulcerative colitis 2016/12
|
|
253.
|
原著(症例報告除く)
|
The ulcerative colitis endoscopic index of severity (UCEIS) is useful to predict medium to long-term prognosis in ulcerative colitis patients with clinical remission 2016/11
|
|
254.
|
総説
|
Indole compounds may be promising medicines for ulcerative colitis 2016/09
|
|
255.
|
原著(症例報告除く)
|
Twice-daily budesonide 2mg foam induces complete mucosal healing in patients with distal ulcerative colitis 2016/07
|
|
256.
|
原著(症例報告除く)
|
Clinical efficacy and safety of oral Qing-Dai in patients with ulcerative colitis: A single-center open-label prospective study. 2016
|
|
257.
|
原著(症例報告除く)
|
Endoscopic severity predicts long-term prognosis in Crohn’s disease patients with clinical remission 2016
|
|
258.
|
原著(症例報告除く)
|
Correlation of the endoscopic and magnetic resonance scoring systems in the deep small intestine in Crohn's disease 2015/08
|
|
259.
|
原著(症例報告除く)
|
Adalimumab for the treatment of Japanese patients with Intestinal Behçet's Disease 2015/05
|
|
260.
|
総説
|
Magnetic resonance enterography of Crohn's disease 2015/01
|
|
261.
|
原著(症例報告除く)
|
The usefulness and problems of central review of evaluations of colonic mucosal findings 2014/11
|
|
262.
|
原著(症例報告除く)
|
Comparison of magnetic resonance and balloon enteroscopic examination of deep small intestine in patients with Crohn's disease 2014/08
|
|
263.
|
原著(症例報告除く)
|
Extracellular adenosine regulates colitis through effects on lymphoid and non-lymphoid cells 2014/08
|
|
264.
|
原著(症例報告除く)
|
活動性潰瘍性大腸炎に対する外来タクロリムス投与の安全性および血中濃度推移に関する探索的検討 2014/02
|
|
265.
|
総説
|
Inflammatory bowel disease and novel endoscopic technologies 2014/01
|
|
266.
|
総説
|
Advancing magnetic resonance imaging in Crohn's disease 2014
|
|
267.
|
原著(症例報告除く)
|
A prospective analysis of the incidence and risk factors for opportunistic infections in patients with inflammatory bowel disease 2013
|
|
268.
|
原著(症例報告除く)
|
Incidence and characteristics of the 2009 influenza (H1N1) infections in inflammatory bowel disease patients. 2013
|
|
269.
|
原著(症例報告除く)
|
Poor recall of prior exposure to varicella zoster, rubella, measles, or mumps in patients with IBD. 2013
|
|
270.
|
原著(症例報告除く)
|
Relationship between non-adherence to aminosalicylate medication and the risk of clinical relapse among Japanese patients with ulcerative colitis in clinical remission: a prospective cohort study 2013
|
|
271.
|
総説
|
Ulcerative colitis: prevention of relapse 2013
|
|
272.
|
症例報告
|
Histologically confirmed IgG4-related small intestinal lesions diagnosed via double balloon enteroscopy. 2012
|
|
273.
|
原著(症例報告除く)
|
Conception and pregnancy outcome in women with inflammatory bowel disease: A multicentre study from Japan. 2011
|
|
274.
|
原著(症例報告除く)
|
Magnetic resonance enterocolonography is useful for simultaneous evaluation of small and large intestinal lesions in Crohn’s disease. 2011
|
|
275.
|
原著(症例報告除く)
|
Safety and usefulness of balloon endoscopy in Crohn’s disease patients with postoperative ileal lesions. 2011
|
|
276.
|
総説
|
The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease. 2011
|
|
277.
|
原著(症例報告除く)
|
Conception outcomes and opinions about pregnancy for men with inflammatory bowel disease. 2010
|
|
278.
|
原著(症例報告除く)
|
Novel endoscopic activity index is useful for choosing treatment in severe active ulcerative colitis 2010
|
|
279.
|
原著(症例報告除く)
|
Rapid endoscopic improvement is necessary for 1-year avoidance of colectomy but not for the long-term prognosis in patients with ulcerative colitis treated with cyclosporine A. 2010
|
|
280.
|
原著(症例報告除く)
|
Efficacy of infliximab for induction and maintenance of remission in intestinal Behçet’s disease. 2009
|
|
281.
|
原著(症例報告除く)
|
A CD8+/CD103high T Cell Subset Regulates TNF-Mediated Chronic Murine Ileitis. 2008
|
|
282.
|
原著(症例報告除く)
|
A pilot open-labeled prospective randomized study between weekly and intensive treatment of granulocyte and monocyte adsorption apheresis for active ulcerative colitis. 2008
|
|
283.
|
症例報告
|
Reactivation of hepatitis B in a patient with Crohn’s disease treated using infliximab. 2008
|
|
284.
|
原著(症例報告除く)
|
Cutting Edge: Critical role for A2A adenosine receptors in the T cell mediated regulation of colitis. 2006
|
|
285.
|
原著(症例報告除く)
|
Interleukin-8 Induction by Helicobacter pylori in Gastric Epithelial Cells is Dependent on Apurinic/Apyrimidinic Endonuclease-1/Redox Factor-1 2006
|
|
286.
|
原著(症例報告除く)
|
Deficiency of the tyrosine phosphatase SHP-1 causes enrichment of CD4+CD25+ regulatory T cells. 2005
|
|
287.
|
原著(症例報告除く)
|
Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease. 2004
|
|
288.
|
原著(症例報告除く)
|
Granulocytopheresis is useful as an alterative therapy for steroid refractory and dependent ulcerative colitis. 2004
|
|
289.
|
原著(症例報告除く)
|
CD4+ Th cells resembling regulatory T cells that inhibit chronic colitis differentiate in the absence of interactions between CD4 and class II MHC. 2003
|
|
290.
|
症例報告
|
A case of Behçet's disease accompanied by colitis with longitudinal ulcers and granuloma 2002
|
|
291.
|
原著(症例報告除く)
|
Characterization of strictures with T-lymphocyte aggregate in ileal villi of Crohn’s disease. 2002
|
|
292.
|
原著(症例報告除く)
|
Appendectomy protects the development of ulcerative colitis and reduces its recurrence: Results of a multi-center, case-controlled study in Japan. 2001
|
|
293.
|
原著(症例報告除く)
|
Measurement of colonic mucosal concentrations of 5-aminisalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: Comparison of orally administered mesalamine and sulfasalazine. 2001
|
|
294.
|
原著(症例報告除く)
|
ステロイド抵抗性・依存性遠位潰瘍性大腸炎に対するメサラミン注腸の有用性 2001
|
|
295.
|
原著(症例報告除く)
|
Analysis of clinical course and long term prognosis of surgical and non-surgical patients with intestinal Behçet's disease. 2000
|
|
5件表示
|
|
全件表示(295件)
|
